Switching multiple sclerosis patients with breakthrough disease to second-line therapy

Tamara Castillo-Trivino, Ellen M. Mowry, Alberto Gajofatto, Dorothee Chabas, Elizabeth Crabtree-Hartman, Bruce A. Cree, Douglas S. Goodin, Ari J. Green, Darin T. Okuda, Daniel Pelletier, Scott S. Zamvil, Eric Vittinghoff, Emmanuelle Waubant

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Switching multiple sclerosis patients with breakthrough disease to second-line therapy'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds